tbuckley/cabot-search huggingface dataset:
Early In Vivo Generation of Vγ9Vδ2 T Cells after Haploidentical Stem Cell Transplant with Post-Transplant Cyclophosphamide: A Monocentric Phase 1 Study
Authors: Maxime Jullien, Thierry Guillaume, Amandine Le Bourgeois, Pierre Peterlin, Alice Garnier, Marion Eveillard, Marie C Béné, Patrice Chevallier
Journal: Blood (2022)
Genomic Sequencing of Paired Bone Marrow and Focal Lesion Biopsies of Newly Diagnosed Multiple Myeloma Patients before and after Induction Therapy
Authors: Yuxin Liu, Sabrina L. Browning, Jennifer VanOudenhove, Giulia Biancon, Noffar Bar, Terri L. Parker, Tara Anderson, Madhav Dhodapkar, Stuart Seropian, Stephanie Halene, Mina L Xu, Elan Gorshein, Ashita Talsania, Wajih Zaheer Kidwai, David H. Witt, Victor Chang, Francesca Montanari, Andrew Lischuk, Andrew Haims, Wei Wei, Natalia Neparidze
Journal: Blood (2022)
Hematological and Non-Hematological Toxicities in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Who Responded to Daratumumab, Pomalidomide, and Dexamethasone (DPd)
Authors: Polina Bellman, Wei Cui, Zahra Mahmoudjafari, Shebli Atrash, Barry Paul, Hamza Hashmi, Rajesh Banderudrappagari, Leyla O. Shune, Al-Ola Abdallah, Nausheen Ahmed
Journal: Blood (2022)
Idecabtagene Vicleucel Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma with Renal Insufficiency: Real World Experience
Authors: Surbhi Sidana, Lauren C. Peres, Hamza Hashmi, Hitomi Hosoya, Christopher J. Ferreri, Shebli Atrash, Jack Khouri, Peter M. Voorhees, Danai Dima, Gary Simmons, Nilesh Kalariya, Vanna Hovanky, Sushma Bharadwaj, Sally Arai, David B. Miklos, Charlotte B Wagner, James Davis, Douglas W. Sborov, Taiga Nishihori, Melissa Alsina, Frederick L. Locke, Rebecca Gonzalez, M. Hakan Kocoglu, Aishwarya Sannareddy, Aimaz Afrough, Joseph P. McGuirk, Leyla O. Shune, Krina Patel, Doris K. Hansen
Journal: Blood (2022)
Efficacy of Novel Non-Chemotherapy Combinations Against AML Cells with Mutant NPM1
Authors: Christopher Peter Mill, Warren C. Fiskus, John A. Davis, Kaberi Das, Christine E Birdwell, Tapan M. Kadia, Koji Sasaki, Koichi Takahashi, Courtney D. DiNardo, Sanam Loghavi, Naval Daver, Kapil N. Bhalla
Journal: Blood (2022)
Pharmacodynamic Results from Phase 1 Studies of GBT021601, a Next-Generation HbS Polymerization Inhibitor for Treatment of Sickle Cell Disease
Authors: Modupe Idowu, Thinh Nguyen, Derek Lewis, Thokozeni Lipato, Erin M. Buckley, Rowan Brothers, Mariam Akbar, Sydney Triplett, Kobina Dufu, Eleanor Lisbon
Journal: Blood (2022)
Subsequent Secondary CAR-T Cell Therapy Was Superior to Chemotherapy in Patients with Refractory/Relapsed B-Cell Lymphoma after Failure of Anti-CD19 CAR-T Cell Therapy
Authors: Fan Yang, Rui Liu, Teng Xu, Peihao Zheng, Shaomei Feng, Yuelu Guo, Lixia Ma, Hui SHI, Biping Deng, Xiaoyan Ke, Tong Wu, Kai Hu
Journal: Blood (2022)
Retinoic Acid Regulates Donor Myeloid Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation in Mice
Authors: Xinlei Li, Jianwei Zheng, Dian Zhou, Rachel Limpert, Brian Taylor, Linlu Tian, Xue-Zhong Yu, William R. Drobyski, Xiao Chen
Journal: Blood (2022)
Survival Disparities Among People with HIV and Diffuse Large B-Cell Lymphoma in the Era of Novel Antiretroviral Therapy
Authors: Daniel A. Ermann, Victoria A. Vardell, Manasa Velagapudi, Greer Burkholder, Lindsey A. Fitzgerald, Mayur Narkhede, Harsh Shah, Lauren Shea, Adam Spivak, Deborah M. Stephens, Boyu Hu, Gaurav Goyal
Journal: Blood (2022)
Synergistic Antileukemic Effect of Mek and Lsd1 Inhibitors Correlates with Decreased Phospho-Serine 315 of TP53
Authors: Alessandra Caroleo, Paul Kerbs, Anja Swoboda, Lucas Wange, Stephanie Heinzlmeir, Yun-Chien Chang, Bernhard Küster, Wolfgang Enard, Michael von Bergwelt, Philipp A. Greif, Monica Cusan
Journal: Blood (2022)
JAK1 Inhibition during CAR T-Cell Treatment Does Not Affect CAR T-Cell Proliferation, Persistence, or Function
Authors: Michael Pratta, Lea Burke, John F. DiPersio, Richard T. Maziarz, Patricia Feldman, Teresa Brodeur, Cynthia Timmers, Olga Ivanova, April Barbour, Rodica Morariu-Zamfir, Matthew Frigault
Journal: Blood (2022)
Mitapivat Improves Markers of Hemolysis and Erythropoiesis in Patients with Pyruvate Kinase Deficiency Irrespective of Hemoglobin Response
Authors: Hanny Al-Samkari, Rachael F. Grace, Eduard J. van Beers, Feng Tai, Jaime Morales-Arias, Vanessa Beynon, Andreas Glenthøj
Journal: Blood (2022)
BMI1 Regulates Proliferation of Human Late-Stage Erythroid Progenitors
Authors: Jayme L. Olsen, Kathleen E. McGrath, Kristin Murphy, Taylor Schofield, Michael Getman, Mohandas Narla, Lionel Blanc, Vincent P Schulz, Patrick G. Gallagher, Laurie A. Steiner, James Palis
Journal: Blood (2022)
A Retrospective Analysis of Prophylactic G-CSF Biosimilar and Originator Administrative Claims over Time Among Patients with Non-Hodgkin Lymphoma
Authors: Pamala A. Pawloski, Cara L. McDermott, Gabriela Vazquez Benitez, Terese A. DeFor, Aaron B. Mendelsohn, James Marshall, Erick Moyneur, Catherine M. Lockhart
Journal: Blood (2022)
Health-Related Quality of Life of Patients with Philadelphia-Negative Myeloproliferative Neoplasms Compared with the General Population: A Preliminary Report from the Gimema Prophecy Study
Authors: Giovanni Caocci, Francesca Palandri, Giuseppe Gaetano Loscocco, Alfonso Piciocchi, Alessandra Iurlo, Alessia Tieghi, Andrea Patriarca, Elisabetta Abruzzese, Simona Tomassetti, Monia Marchetti, Daniele Vanni, Mario Luppi, Fabrizio Pane, Massimo Breccia, Sergio Siragusa, Elena Maria Elli, Alessandra Ricco, Claudio Fozza, Maria Teresa Corsetti, Carmen Fava, Camilla Mazzoni, Paola Fazi, Giorgio La Nasa, Marco Vignetti, Alessandro M. Vannucchi, Fabio Efficace
Journal: Blood (2022)
The Association of Agent Orange Exposure Duration with Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma Progression: A Population-Based Study
Authors: Lawrence Liu, Mei Wang, Nikhil Grandhi, Mark A. Schroeder, Theodore S. Thomas, Akhil Kumar, Kristin Vargo, Feng Gao, Kristen M. Sanfilippo, Su-Hsin Chang
Journal: Blood (2022)
LP-118, a Novel BCL2 Inhibitor, Shows Potent in Vitro Anti-Myeloma Activity
Authors: Rodrigo Fonseca, Yuan Xiao Zhu, P. Leif Bergsagel, Marta Chesi, Akhilesh Pandey, Kiran Mangalaparthi, Yi Chen, Felai Tan, Stephen P. Anthony, Yu Chen, Yue Shen, Bing Dai, Esteban Braggio, Rafael Fonseca
Journal: Blood (2022)
Spatial Transcriptomics Reveals a Multi Cellular Ecosystem in Extramedullary Multiple Myeloma
Authors: Moutaz Helal, Mara John, Emilia Stanojkovska, Greta Mattavelli, Lars Grundheber, Alexander Leipold, Nazia Afrin, Christine Riedhammer, Johannes Duell, Max Johannes Steinhardt, Julia Mersi, Hermann Einsele, Kai Kretzschmar, K. Martin Kortuem, Angela Riedel, Leo Rasche
Journal: Blood (2022)
Randomized Comparison between Krd and Ktd Induction, Followed By K Maintenance or Control in Transplant Non-Eligible Patients with NDMM: Efficacy and Qol Data (AGMT-MM02 Trial)
Authors: Heinz Ludwig, Thomas Melchardt, Siegfried Sormann, Niklas Zojer, Johannes Andel, Bernd L. Hartmann, Christoph Tinchon, Eberhard Gunsilius, Klaus Podar, Alexander Egle, Wolfgang Willenbacher, Ewald Wöll, Martin Schreder, Reinhard Ruckser, Boris Bozic, Maria-Theresa Krauth, Andreas Petzer, Clemens A. Schmitt, Sigrid Machherndl-Spandl, Hermine Agis, Michael Fillitz, Song-Yau Wang, Stefan Knop, Sarah Kainz, Bruno Paiva, Richard Greil
Journal: Blood (2022)
Spatial-Temporal Multiomic Analysis of Tumor-Immune Interactions in Patients with AML Receiving Pembrolizumab and Decitabine
Authors: Gege Gui, Abigail Wong-Rolle, Laura W. Dillon, Meghali Goswami, Eddie Martin, Prajan Divakar, Jason Reeves, Katherine R. Calvo, Kasper D. Hansen, Christopher S. Hourigan, Chen Zhao
Journal: Blood (2022)
Early and Sustained Undetectable Measurable Residual Disease (MRD) after Idecabtagene Vicleucel (ide-cel) Defines a Subset of Multiple Myeloma (MM) Patients in Karmma Achieving Prolonged Survival
Authors: Bruno Paiva, Irene Manrique, Julie A Rytlewski, Timothy B. Campbell, Christian Kazanecki, Nathan Martin, Shari M. Kaiser, Larry D. Anderson, Jesus Berdeja, Sagar Lonial, Noopur Raje, Yi Lin, Philippe Moreau, Jesús San-Miguel, Nikhil C Munshi
Journal: Blood (2022)
Distinct Immune Homeostasis Remodeling Patterns after HLA-Matched and Haploidentical Transplantation
Authors: Huidong Guo, Liping Guo, Bixia Wang, Ming Wang, Yan Hong, Xiao-Dong Mo, Yuqian Sun, Yuan-Yuan Zhang, Zhidong Wang, Jun Kong, Chen-Hua Yan, Yu Wang, Lan-Ping Xu, Xiaohui Zhang, Ying-Jun Chang, Xiao-Jun Huang
Journal: Blood (2022)
ERK2 Substrate Binding Domains Play Distinct Roles in Megakaryocytic-Erythroid Lineage Progression and Mediates Clonal Fitness in Myeloproliferative Neoplasms
Authors: Billy Truong, Yong Zhang, Esteban Martinez, Brianna Trankle, Anna-Mariya Kukuyan, Susan Shinton, James Oesterling, Xiang Hua, Dietmar J Kappes, Joan Font-Burgada, Tomasz Skorski, David Wiest
Journal: Blood (2022)
Forodesine Amplifies Host Innate Immune Response through Toll-like Receptor 7 Activation While Preventing Experimental Graft-Versus-Host Disease
Authors: Takashi Ikeda, Kazuya Sato, Shinichiro Kawaguchi, Hirofumi Nakano, Junko Izawa, Norihito Takayama, Hiroko Hayakawa, Takashi Nagayama, Kento Umino, Kaoru Morita, Kana Matsumoto, Kentaro Ushijima, Yoshinobu Kanda
Journal: Blood (2022)
The Downgraded Lymphoma: Case Series of High-Grade Lymphoma Relapsing As a Low-Grade after Treatment
Authors: Arthur G.O. Braga, João Victor A. Castro, Anita C. Cortez, Humberto V.S. Chaves, Marina M. Nascimento, Fernanda L.M. Gallo, Thais R.C. Fischer, Jayr Schmidt-Filho, Felipe D'A. Costa, Talita M.B. Silveira
Journal: Blood (2022)
T Cell Receptor-Based Targeting of Immunoglobulin Constant Domains for Treatment of Multiple Myeloma
Authors: Miranda H. Meeuwsen, Anne K. Wouters, Tassilo L.A. Wachsmann, Renate S. Hagedoorn, Dennis F.G. Remst, Michel G.D. Kester, Dirk M. van der Steen, Arnoud H. de Ru, Peter A. van Veelen, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk
Journal: Blood (2022)
Donor-Derived, <i>I</i> <i>n Vivo</i> T-Cell Expansion Using Granulocyte Transfusions after Cord Blood Transplant Induces Remission in Children with Relapsed, Refractory Acute Myeloid Leukemia and Is Associated with a Cytokine Release Syndrome
Authors: Roisin Borrill, Helen Campbell, Denise Bonney, Ramya Nataraj, Madeleine Powys, Omima Abdalla Mustafa, Laura Kusyk, Tracy Hussell, Suzy Morton, Simon Stanworth, Kay Poulton, Joanne Konkel, Robert Wynn
Journal: Blood (2022)
Tcrαβ+/CD19+-Depletion in Hematopoietic Stem Cells Transplantation from Matched Unrelated and Haploidentical Donors in Pediatric Acute Lymphoblastic Leukemia Patients in Complete Remission
Authors: Larisa Shelikhova, Rimma Khismatullina, Dmitriy Balashov, Alexey Kazachenok, Yakov Muzalevsky, Julia Abugova, Julia Skvortsova, Alexander Popov, Dmitry Pershin, Daria Kobyzeva, Alexey Nechesnyuk, Yulia Olshanskaya, Svetlana Kozlovskaya, Sergey Blagov, Natalia Miakova, Galina Novichkova, Alexey Maschan, Michael Maschan
Journal: Blood (2022)
Acute Myeloid Leukemia during the COVID Pandemic: Impact and the Indian Experience
Authors: Chepsy C Philip, Sushil Selvarajan, Lingaraj Nayak, Hasmukh Jain, Uday Prakash Kulkarni, Prasanna Samuel, Narendra Agrawal, Smita Kayal, Kundan Mishra, Pavitra D S, Smita Das, Jayachandran PK, Stalin Chowdary Bala, Vineetha Raghavan, Mobin Paul, Jagdeep Singh, Prashant Mehta, Sreeraj Vasudevan, Swaratika Majumdar, Akshatha Nayak, Om Prakash, Marimuthu S, Akhil Rajendra, Jayashree Thorat, Bhausaheb Bagal, Aby Abraham, Dinesh Bhurani, Prasanth Ganesan, Manju Sengar, Vikram Mathews
Journal: Blood (2022)
Multiple Myeloma-Derived Circulating Extracellular Vesicles Affect Normal Human Stromal Cell Behaviour and Promote Tumor Progression: A Multi-Omic Approach
Authors: Antonia Reale, Irena Carmichael, Rong Xu, Haoyun Fang, Jaynish S Shah, Tiffany Khong, Nicholas Bingham, Malarmathy Ramachandran, Maoshan Chen, David W Greening, Andrew Spencer
Journal: Blood (2022)
Exogenous M-CSF Protects from Lethal <i>a. Fumigatus</i> pulmonary Infection By Tissue-Resident Alveolar Macrophages Early after Hematopoietic Cell Transplantation
Authors: Dalia Sheta, Andreas Beilhack, Hermann Einsele, Katrin G Heinze, Zeinab Mokhtari, Jorge Amich, Ulrich Terpitz, Nora Trinks, Marlene Strobel, Yidong Yu
Journal: Blood (2022)
CAR-T Related Cytopenia Profile in Relapsed/Refractory Multiple Myeloma: Results of Patients Treated with ARI0002h, an Academic BCMA-Directed CAR-T Cell
Authors: Aina Oliver-Caldes, Luis Gerardo Rodríguez-Lobato, Veronica Gonzalez-Calle, Natalia Tovar, Valentin Cabañas, Paula Rodríguez-Otero, Juan Luis Reguera, Marta Español-Rego, Beatriz Martin-Antonio, Aintzane Zabaleta, Marta Lasa, Susana Inogés, Ascensión López-Diaz de Cerio, Bruno Paiva, Sara Varea, Joaquin Saez-Peñataro, Manel Juan, Laura Rosiñol, Felipe Prosper, Jose M. Moraleda, Álvaro Urbano-Ispizua, Mariona Pascal, Maria-Victoria Mateos, Carlos Fernandez de Larrea
Journal: Blood (2022)
Characteristics and Safety Profile in Patient Received Ixazomib in China: Interim Analysis of a National, Prospective, Non-Interventional Study of Using Ixazomib in Real-World Clinical Practice (INFINITE Study)
Authors: Chengcheng Fu, Xin Zhou, Junling Zhuang, Fan Zhou, Yuhua Li, Wenming Chen, Rong Fu, Baijun Fang, Ting Niu, Hao Zhang, Lin Li, Depei Wu
Journal: Blood (2022)
Updated Results from a Phase I/II Study of the Triplet Combination of Azacitidine, Venetoclax and Gilteritinib for Patients with <i>FLT3</i>-Mutated Acute Myeloid Leukemia
Authors: Nicholas Short, Courtney D. DiNardo, Naval Daver, Walid Macaron, Musa Yilmaz, Gautam Borthakur, Guillermo Montalban-Bravo, Guillermo Garcia-Manero, Ghayas C. Issa, Koji Sasaki, Philip A. Thompson, Jan A. Burger, Abhishek Maiti, Yesid Alvarado, Monica Kwari, Ricardo Delumpa, Jennifer Thankachan, Ejiroghene Mayor, Christopher Loiselle, Anna Milton, Glenda Banks, Tapan M. Kadia, Marina Konopleva, Hagop Kantarjian, Farhad Ravandi
Journal: Blood (2022)
Complex Formation between FANCD2 and the Splicing Factor SRSF1 Helps Prevent R-Loop Accumulation through mRNA Export Regulation
Authors: Anne Olazabal Herrero, Fengshan Liang, Arijit Dutta, Yuxin Huang, Zhuobin Liang, Abhishek K Gupta, Li Lan, Manoj M Pillai, Patrick Sung, Gary M. Kupfer
Journal: Blood (2022)
Peri-Transplant and Maintenance Daratumumab for Minimal Residual Disease (MRD) Eradication in Transplant-Eligible Multiple Myeloma (MM) Patients
Authors: Sikander Ailawadhi, Ricardo D Parrondo, Gabriela Perez, Mohamed A. Kharfan-Dabaja, Hemant S. Murthy, Ernesto Ayala, Patrick J O'Brien, Vivek Roy, Victoria R. Alegria, Ashley Zimmerman, Dustin Chapin, Stephanie Lanier, Carly Kasik, Schannon Bradley, Taimur Sher, Aneel Paulus, Asher Chanan-Khan
Journal: Blood (2022)
Diffuse Large B-Cell Lymphoma (DLBCL): A Structured Literature Review of the Epidemiology, Treatment Guidelines, and Real-World Treatment Patterns
Authors: Mahek Garg, Jitender Takyar, Arju Dhawan, Gurkiran Saggu, Neha Agrawal, Adam Hall, Monika Raut, Katherine Elizabeth Ryland
Journal: Blood (2022)
Tuned IL3-Zetakine Coupled to a CD33 Costimulatory Receptor As a Dual CAR for Safer and Selective Targeting of Acute Myeloid Leukemia
Authors: Vincenzo Maria Perriello, Maria Caterina Rotiroti, Ilaria Pisani, Stefania Galimberti, Gaia Alberti, Giulia Pianigiani, Valerio Ciaurro, Andrea Marra, Marcella Sabino, Valentina Tini, Federica Mezzasoma, Francesco Morena, Sabata Martino, Domenico Salerno, Julian François Ashby, Brittany Wingham, Marta Serafini, Maria Paola Martelli, Brunangelo Falini, Andrea Biondi, Sarah Tettamanti
Journal: Blood (2022)
Soluble Factors Correlated with High-Grade Cytokine Release Syndrome (CRS): A Comparison of Subcutaneous (SC) Versus Intravenous (IV) Delivery of Alnuctamab (ALNUC; BMS-986349; CC-93269) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)
Authors: Isaac W. Boss, Ethan Thompson, Allison M. Gaudy, Minh Diem Vu, Colin D. Godwin, Michael R. Burgess, Sandy W. Wong, Luciano J. Costa
Journal: Blood (2022)
MM-SZ01 Study: A Prospective, Randomized, Controlled, Multicenter Phase III Clinical Study Which Compared Polyethylene Glycol Liposomal Doxorubicin Versus Doxorubicin Combined with Bortezomib and Dexamethasone (PDD regimen vs PAD regimen) in the Treatment of Newly Diagnosed Multiple Myeloma in China
Authors: Qingqing Wang, Depei Wu, Chengcheng Fu, Shuang Yan, ChengHao Jin, Xuzhang Lu, Tao Chen, Fei Li, Zhongjun Xia, Bingzhong Li
Journal: Blood (2022)
Obesity Is Associated with Adverse Outcomes in Primary Immune Thrombocytopenia
Authors: Zhengrui Xiao, Zhiqiang He, Hieu Liem Le Nguyen, Rahul Kumar Thakur, M Bakri Hammami, Hiba Narvel, Charan Thej Reddy Vegivinti, Irina Murakhovskaya
Journal: Blood (2022)
Oligosecretory Waldenström Macroglobulinemia Patients Exhibit Excellent Treatment Response and Outcomes
Authors: Ying Yu, Wenjie Xiong, Zanzan Wang, Yuting Yan, Jiawen Chen, Yanshan Huang, Xinxin Cao, Zhongxing Jiang, Huihan Wang, Zhen Cai, Juan Du, Chunyan Sun, Ting Niu, Guangzhong Yang, Hua Xue, Bingzong Li, Honghui Huang, Zhenling Li, Qinhua Liu, Fei Li, Ou Bai, Min Mao, Rong Fu, Ling Wang, Chunrui Li, Xiaoxia Chu, Lihong Liu, Yujun Dong, Luqun Wang, Jun Luo, Yongqiang Wei, Lugui Qiu, Jian Li, ShuHua Yi
Journal: Blood (2022)
Prognostic Significance of 18f-FDG PET/CT in the Treatment of Primary Central Nervous System Lymphoma
Authors: Ga-Young Song, Sung-Hoon Jung, Seo-Yeon Ahn, Mihee Kim, Jae-Sook Ahn, Je-Jung Lee, Hyeoung-Joon Kim, Su Woong Yoo, Seong Young Kwon, Jung-Joon Min, Hee-Seung Bom, Sae-Ryung Kang, Deok-Hwan Yang
Journal: Blood (2022)
Preliminary Results from the Launch Study-a Multicenter, Open-Label Study of Selinexor, Dexamethasone and Chemotherapy Drugs in Relapsed/ Refractory Multiple Myeloma
Authors: Chunyan Sun, Fei Zhao, Junying Li, Chun Zhang, Weiming Li, Hui Cheng, Huili Cai, Bin Chen, Jingming Guo, Jay Mei, Yu Hu
Journal: Blood (2022)
SHP2 Inhibition Suppresses RAS-ERK Signaling, the Development of JAK2 Inhibitor Persistence, and MPN Development in Pre-Clinical Models of Myeloproliferative Neoplasms
Authors: Garima Pandey, Nathan Horvat, Narmin E. Amin, Guolin Zhang, Lucia Mazzacurati, Afua A. Akuffo, Christelle Colin-Leitzinger, Eric B. Haura, Pearlie K. Epling-Burnette, Gary W. Reuther
Journal: Blood (2022)
Long-Term Hemoglobin Response and Reduction in Transfusion Burden Are Maintained in Patients with Pyruvate Kinase Deficiency Treated with Mitapivat
Authors: Rachael F. Grace, Andreas Glenthøj, Wilma Barcellini, Madeleine Verhovsek, Jennifer A. Rothman, Marta Morado, D. Mark Layton, Oliver Andres, Frédéric Galactéros, Eduard J. van Beers, Koichi Onodera, Vip Viprakasit, Satheesh Chonat, Malia P. Judge, Penelope A. Kosinski, Peter Hawkins, Sarah Gheuens, Emily Xu, Bryan McGee, Vanessa Beynon, Hanny Al-Samkari
Journal: Blood (2022)
Bortezomib and/or Daratumumab for Treatment of Refractory Autoimmune Hemolytic Anemia
Authors: John McGlothlin, Jithma P. Abeykoon, Eyad Al-Hattab, Aneel A. Ashrani, Michelle A Elliott, Ronald Go, C. Christopher Hook, Animesh Pardanani, Rajiv K. Pruthi, Meera Sridharan, Alexandra P. Wolanskyj
Journal: Blood (2022)
Impact of Sociodemographic and Socioeconomic Factors on Diffuse Large B-Cell Lymphoma (DLBCL)-Specific Mortality in the United States - a SEER PLUS Database Analysis Spanning 20 Years
Authors: Sujitha Ketineni, Calvin Abro, Xianming Zhu, Vivek Prakash, Sarah S. Makhani, Kathy Robinson, Aliyah Hashmi, Bhavya Vemuri, Mohammad Hussain, Ruchika Goel
Journal: Blood (2022)
Engineered Stem Cell Antibody Paired Evasion-2 (ESCAPE-2): Paired HSC Epitope Engineering and Direct Editing of Sickle Allele for Antibody-Mediated Autologous Hematopoietic Stem Cell Therapy Conditioning for the Treatment of Sickle Cell Disease
Authors: S. Haihua Chu, Elizabeth Budak, Nandini Mondal, Kathy Zhang, Alexander Harmon, Jeffrey Wong, Dieter Lam, Corrina Lucini, Brent Coisman, Kangjian Qiao, Tao Bai, Jeremy Decker, Bob Gantzer, Kindo Lee, Maya Sen, Tanggis Bohnuud, Luis Barrera, Brian Cafferty, Seung-Joo Lee, Paul Kopesky, Nicole M. Gaudelli, Charlotte F McDonagh, Giuseppe Ciaramella, Adam J. Hartigan
Journal: Blood (2022)
Tafasitamab (TAFA) Plus Lenalidomide (LEN) Prior to Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Case Series of 8 Patients
Authors: Muthu Veeraputhiran, Amitkumar Mehta, Alvaro J. Alencar, Dipenkumar Modi, Timothy J. Voorhees, Mayur Narkhede
Journal: Blood (2022)
Comorbidities and Complications in Pediatric Patients with Pyruvate Kinase Deficiency Enrolled in the Peak Registry
Authors: Rachael F. Grace, Andreas Glenthøj, Carl Lander, Eduard J. van Beers, Hitoshi Kanno, Joan-Lluis Vives Corrons, Paola Bianchi, Dagmar Pospíšilová, Jean Williams, Yan Yan, Bryan McGee, Bert Glader
Journal: Blood (2022)
Interim Analysis of a Phase 2 Trial to Assess the Efficacy and Safety of Crizanlizumab in Sickle Cell Disease Patients with Priapism (SPARTAN)
Authors: Alan Anderson, Fuad El Rassi, Michael R. DeBaun, Modupe Idowu, Julie Kanter, Soheir Adam, Susanna Curtis, Darla Liles, Biree Andemariam, Morgan L. McLemore, Robert Sheppard Nickel, Poornima Ramadas, Jincy Paulose, Dramane I Laine, Mahmudul Khan, Deepika S. Darbari, Arthur L. Burnett
Journal: Blood (2022)
Feasibility and Preliminary Findings of a Novel, Patient-Centric Registry Model to Address Real-World Care Questions for Patients with Hematologic Malignancies
Authors: Sophia C Cornew, Anthony B Cardillo, Louis J DeGennaro, Paul A Fields, Lore M Gruenbaum, Hana Littleford, Richard L Martin, Gwen L Nichols, Amanda C Nottke, Conner M O'Brien, Sneha T Reddy, Rhonda Rosenbaum, Larry A Saltzman, Catherine Sanders, Jun Xu, Lee M Greenberger
Journal: Blood (2022)
A First-in-Human Phase 1 Dose Escalation and Expansion Study of the Oral CARD11-BCL10-MALT1 Signaling Pathway Inhibitor XL114 in Patients with Non-Hodgkin's Lymphoma
Authors: Bert H. O'Neil, Willy Solis, Sofia Vidal-Cardenas, Shailaja Uttamsingh, Abhijeet Kumar
Journal: Blood (2022)
5-Azacytidine and Venetoclax Combination Boost Vγ9Vδ2 T Cell Effector Functions
Authors: Anne-Charlotte Le Floch, Elisabeth Wieduwild, Anne-Sophie Chretien, Florence Orlanducci, Céline Garulli, Sarah Bourass, Caroline Imbert, Aude De Gassart, Norbert Vey, Loui Madakamutil, Daniel Olive
Journal: Blood (2022)
Outcomes of Relapsed Refractory Double Hit Lymphoma: A Multicenter Observational Cohort
Authors: Sanjal H Desai, Marcus P. Watkins, Reem Karmali, Gaurav Goyal, Mitchell Hughes, Arushi Khurana, Francisco Hernandez-Ilizaliturri, Nuttavut Sumransub, Joanna Zurko, Imran A. Nizamuddin, Haris Hatic, Daniel A Landsburg, Andrea Anampa-Guzman, Mehdi Hamadani, Yi Lin, Iris Isufi, Aung M Tun, Brian T. Hill, Deborah M. Stephens, Paolo F Caimi, Daniel A. Ermann, Brad S. Kahl, Grzegorz S. Nowakowski
Journal: Blood (2022)
Targeting Intestinal Epithelial Ceacam1 Expands Peripheral Tregs and Prevents Steroid-Refractory Acute Gut Graft-Versus-Host Disease
Authors: Qingxiao Song, Moqian Zheng, Qinjian Li, Xiwei Wu, Hanjun Qin, Tae Hyuk Kang, Yaqun Hong, Bixin Wang, Maciej Kujawski, Jack Shively, Ryotaro Nakamura, Paul J Martin, Defu Zeng
Journal: Blood (2022)
ZUMA-19: A Phase 1/2 Study of Axicabtagene Ciloleucel Plus Lenzilumab in Patients With Relapsed or Refractory Large B-Cell Lymphoma
Authors: Olalekan O. Oluwole, Saad S. Kenderian, Parveen Shiraz, Reem Karmali, Ran Reshef, Philip L. McCarthy, Nilanjan Ghosh, Aleksandr Lazaryan, Simone Filosto, Soumya Poddar, Daqin Mao, Andrew Peng, Adrian Kilcoyne, Myrna Nahas, Sattva S. Neelapu
Journal: Blood (2022)
Ogdh Is a Genetic Vulnerability and Therapeutic Target in Acute Myeloid Leukemia
Authors: Scott E Millman, Almudena Chaves-Perez, John P Morris, Chi-Chao Chen, Yu-Jui Ho, Sudha Janaki Raman, Jossie J Yashinskie, Riccardo Mezzadra, Varun Narendra, Sha Tian, Alexandra Wuest, Wei Luan, Justin R Cross, Lydia WS Finley, Scott W Lowe
Journal: Blood (2022)